Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT00373347
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Sponsor: Stanford University
View on ClinicalTrials.gov
Summary
The purpose of this study is to identify blood markers that have the ability to diagnose liver cancer with improved accuracy, so that it can be used alone or in conjunction with alpha-feto protein (AFP)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
573
Start Date
2004-11
Completion Date
2024-11-18
Last Updated
2026-04-17
Healthy Volunteers
No
Conditions
Locations (1)
Stanford University School of Medicine
Stanford, California, United States